Phase 3, Multicenter OpenâLabel study to investigate the efficacy of elbasvir and grazoprevir fixedâdose combination for 8 weeks in treatmentânaïve, HCV GT1bâinfected patients, with nonâsevere fibrosis
Abergel, Armand, Asselah, Tarik, Mallat, Arianne, Chanteranne, Brigitte, Faure, Frederic, Larrey, Dominique, Gournay, Jerome, LoustaudâRatti, Veronique, Di Martino, Vincent, FouchardâHubert, IsabeJournal:
Liver International
DOI:
10.1111/liv.14502
Date:
June, 2020
File:
PDF, 410 KB
2020
File converter
More search results
More benefits 
